Cite this article
Vancouver
Bajaj N, Shaaban H, Maroules M, Guron G. Pomalidomide: A novel imunomodulatory drug for the treatment of relapsed and refractory multiple myeloma. Clin Cancer Investig J. 2014;3(3):200-7.
https://doi.org/10.4103/2278-0513.132109
APA
Bajaj, N., Shaaban, H., Maroules, M., & Guron, G. (2014). Pomalidomide: A novel imunomodulatory drug for the treatment of relapsed and refractory multiple myeloma.
Clinical Cancer Investigation Journal, 3(3), 200-207.
https://doi.org/10.4103/2278-0513.132109